Abstract. This study was designed to compare the effects of different ways of administering carbon monoxide (intravenous and inhalative) on gastric mucosal oxygenation in a canine model of hemorrhage. Six chronically instrumented dogs were repeatedly anesthetized and randomized to each of the following protocols: In a first series the animals were ventilated either with 100 ppm carbon monoxide (CO) or without followed by hemorrhage and re-transfusion. In a second series a saturated CO solution was infused, compared to normal saline, again followed by hemorrhage and re-transfusion. In a control series, animals received either CO-saline or saline without any further intervention. Microvascular oxygenation of the gastric mucosa (µHbO 2 ) was assessed continuously by tissue reflectance spectrophotometry. Cardiac output was measured intermittently and oxygen delivery (DO 2 ) was calculated. The application of CO, inhalative and intravenous, increased carboxyhemoglobin levels without effect on µHbO 2 . Hemorrhage reduced µHbO 2 in all groups, paralleled by a reduction in DO 2 without any differences between groups related to the application of CO. Neither intravenous nor inhalative application of CO alters µHbO 2 during physiological conditions or during hemorrhage. Thus, independent of the application way, low dose CO does not seem to modulate regional mucosal oxygenation in cytoprotective concentrations.
Introduction
The gastrointestinal tract is a complex organ system with multiple functions. Apart from being responsible for nutrient absorption it is an important metabolic and immunological system, functioning as an effective barrier against endotoxin and bacteria from the intestinal lumen. To maintain this barrier adequate perfusion and oxygenation of the mucosa are vital (Russellet al. 1995; Trzeciak et al. 2007 Trzeciak et al. , 2008 .
However, during severe illness (e.g. sepsis or hypovolemia), the blood flow is redistributed to preserve perfusion of more vital organs (i.e. heart and brain) and thus splanchnic oxygenation is impaired early (Jakob and Takala 2000) . Impairment of the splanchnic blood flow and microcirculation often persists despite adequate fluid resuscitation sufficient to restore global circulatory variables (Edouard et al. 1994 ). An impaired mucosal barrier function resulting from insuf-ficient microcirculatory oxygen supply has been shown to enable translocation of bacteria and bacterial toxins into portal venous and local lymphatic circulation (Deitch et al. 2004) and to mediate an inflammatory response syndrome (Chen et al. 2003) . Therefore, adequate splanchnic perfusion and in particular oxygenation of the gastrointestinal mucosa are considered crucial for the prevention and therapy of critical illness (Trzeciak et al. 2007 (Trzeciak et al. , 2008 . Thus, growing effort is made to develop strategies to improve splanchnic mucosal oxygenation.
A lot of signalling molecules are known to mediate vasodilation (e.g., NO) and might influence microcirculation and oxygen supply of the splanchnic region. The signalling function of carbon monoxide (CO) just recently emerged, but its impact on gastric mucosal perfusion and oxygenation is promising but yet unknown.
For a long time, CO was only associated with its acute and chronic toxicity on animals and humans. However, CO is produced endogenously by the activity of hemoxygenases (HOs), mainly during hemoglobin degradation. Only a small fraction is derived from the degradation of other heme proteins like myoglobin, catalyse, peroxidases and cytochromes (Berk et al. 1974 1 ). Under pathophysiological conditions additional sources are lipid peroxidation (Vreman et al. 1998 ) and metabolic activity of intestinal bacteria (Engel et al. 1972) . CO exerts vasoactive, anti-proliferative, anti-oxidant, anti-inflammatory and anti-apoptotic effects and contributes substantially to the important role of the inducible isoform HO-1 as a mediator of tissue protection and host defense (Bauer and Pannen 2009 ). Furthermore it acts as transcriptional activator (Aono et al. 2000) . Effects like these, mediated by gaseous molecules like CO, do not depend on one specific receptor and accordingly they can produce myriad effects virtually simultaneously (Kajimura et al. 2010) . For example, vasoactive effects of CO are mediated via activation of sGC/cGMP (Boehning and Snyder 2003) , although CO serves as partial antagonist in the presence of NO in vitro (Kajimura et al. 2003) , and directly via the activation of calcium-dependent potassium channels in vascular smooth muscle cells (Wang et al. 1997) . This leads to vasodilation and exerts beneficial effects on several organ systems, i.e., the heart (Nishikawa et al. 2004) , kidneys (Hosgood et al. 2008) , lung (Hartsfield et al. 2004) , liver (Pannen et al. 1998) , and brain (Kanu et al. 2006) .
Those vasodilatory effects are known to affect microcirculation in a hamster window chamber model as well and can also be mediated by low doses of exogenous CO that do not even increase CO-Hb (Hangai-Hoger 2007) , which could thus allow a therapeutic use of CO. Currently several means of application are available for exogenous CO (inhalation (Kanten et al. 1983) or intraperitoneal (Gutierrez et al. 1985) and intravenous (Hangai-Hoger 2007) infusion). However, effects might not only depend on systemic concentration but rather depend on the amount of gas actually delivered to the given target, e.g. microvessels of the gastric mucosa. This depends not only on properties of the gas itself, but also on the local environment, e.g. viscosity, temperature or tissue composition and chemical reactions that might consume the gas (Kajimura et al. 2010) . Thus, it is yet unknown whether vasodilatory effects of the hamster window chamber model can be transferred to other tissues and hence whether exogenous CO positively affects gastric mucosal oxygenation and if the way of application modifies this effect.
CO attenuated the surgically-induced molecular inflammatory response and prevented a postoperative ileus (Moore et al. 2005) . Furthermore, it reduced mortality after intestinal transplantation (Nakao et al. 2003) and during microbial sepsis in mice (Chung et al. 2008) which suggests a beneficial effect of CO in the intestine. This is confirmed by findings that HO-2 is localized in neurons of the myenteric plexus of the gut and colocalized with NO-synthase (Boehning and Snyder 2003) which produces another vasoactive transmitter (NO) in gastrointestinal vessels (Zakhary et al. 1996) . More and more studies suggest parallelism between the biological actions and functions of the CO-and NOgenerating systems; and their regulation is intimately linked (Maines 1997) . Some in vitro studies suggest inhibition of NO-synthase by CO, however, this requires high concentrations which cannot be found in vivo, unless they could be achieved locally (Kajimura et al. 2010) . Still, the HO-CO system might downregulate NO-synthase activity by reducing substrate availability as both HO and NO-synthase use the same substrate, i.e. NADPH. Therefore CO is discussed to be in part a vasoconstrictor as well and different effects at different organs are attributed to different receptor systems and different colocalization with NO-synthase.
During stress and pathological conditions, e.g. hemorrhage, induction of hemeoxygenase is triggered due to ischemia/hypoxia (HO-1) and adrenal glucocorticoids (HO-2) (Maines 1997) . In addition, the exogenous application of CO-bound hemoglobin seemed to be beneficial in a model of hemorrhagic shock (Sakai et al. 2009 ).
These data suggest a modulatory role of CO on microvascular gastric mucosal perfusion and oxygenation. CO might be able to restore and maintain mucosal barrier function in severe illness especially during hemorrhagic shock. Therefore, the aim of this study was to evaluate the impact of CO on gastric mucosal oxygenation under physiological and hemorrhagic conditions and to compare the effectiveness of different ways of application, i.e., intravenous to inhalative.
Materials and Methods

Animals
The data were derived from repetitive experiments on six dogs (female foxhounds, weighing 28 ± 1 kg). Prior to the experiments, food was withheld for 12 h with water ad libitum to ensure complete gastric depletion and to avoid perfusion/oxygenation changes due to digestive activity. Each dog underwent two experimental protocols in a first series and four experimental protocols in a second series in randomized order. Experiments were performed at least 2 weeks apart to prevent carryover effects. The experiments were performed under general anaesthesia (induction of anaesthesia with 4 mg·kg -1 propofol, maintenance with sevoflurane, end-tidal concentration 3.0%, 1.5 minimum alveolar concentration (MAC) in dogs (Kazama and Ikeda 1988) ). The animals were mechanically ventilated after endotracheal intubation (inspiratory oxygen concentration F i O 2 = 0.25, tidal volume VT = 12.5 ml·kg -1 ) with the respiratory frequency adjusted to achieve normocapnia (end-expiratory concentration of carbon dioxide etCO 2 = 35 mmHg), verified by continuous capnography (Capnomac Ultima, Datex Instrumentarium, Helsinki, Finland) . During the experiments, the dogs were placed on their right side covered with warming blankets to maintain body temperature within the physiological range for dogs (37-38.5°C, continuous arterial measurement). Throughout the experiments, no extra fluids apart from the interventions were administered to avoid volume effects that could influence tissue perfusion and oxygenation. However, after each blood sample, normal saline was infused three times the sampling volume to maintain the blood volume.
Ethical approval for this study was provided by the local District Governmental Animal Investigation Committee. Animals were treated in accordance with NIH guidelines for animal care.
Measurements
Gastric mucosal oxygenation
Microvascular oxygen saturation (µHbO 2 ) of the gastric mucosa was continuously assessed by a method of the socalled O2C ("oxygen to see") which assesses µHbO 2 by tissue reflectance spectrophotometry (device name "O2C", LEA Medizintechnik, Gießen, Germany), as detailed previously (Frank et al. 1989; Krug 2006) .
Briefly, the flexible light-guide probe is introduced into the stomach non-traumatically via an orogastric silicone tube. White light (450-1000 nm) is transmitted to the tissue of interest, in this case the gastric mucosa, via the microlightguide and the reflected light is then analyzed in vivo. Thus, no tissues have to be removed from the dogs and gastric mucosa remains intact. Therefore it is possible to analyse different interventions at the same healthy, undamaged tissue. The wavelength-dependent absorption of the applied white light can be used to calculate the percentage of oxygenated hemoglobin (Kuchenreuther et al. 1996) . Common pulse oximeters analyze only two wavelengths (660 and 940 nm) where CO-Hb and oxygenated Hb cannot be separated (Barker and Tremper 1987; Zijlstra et al. 1991) . In contrast, the O2C analyses almost the entire spectrum from 500-800 nm (Krug 2006) , where absorption spectra of oxyhemoglobin and carboxyhemoglobin differ substantially (Zijlstra and Buursma 1987) . Therefore measurement of oxygenated hemoglobin is not affected by low concentrations of CO-Hb.
Since light is totally absorbed in vessels with a diameter >100 µm (Gandjbakhche et al. 1999) , only microvascular oxygenation of nutritive vessels of the mucosa is measured. The biggest fraction of the blood volume is stored in venous vessels, therefore mainly postcapillary oxygenation is measured which represents the critical partial pressure of oxygen (pO 2 ) for ischemia (Siegemund et al. 1999) .
The flexible light-guide probe is positioned facing the greater curvature (Scheeren et al. 2002) , a site demonstrated to represent the microvascular oxygenation of other gastric and upper intestinal mucosa regions (Temmesfeld-Wollbruck et al. 1998) . Online evaluation of the signal quality throughout the experiments allows verification of the correct position of the probe tip. The µHbO 2 values reported are the means of the last 5 min (150 spectra, 2 s each) of the respective intervention under steady state conditions. This method allows detection of splanchnic ischemia with similar precision as laser flowmetry (Leung et al. 1987) , intra-vital microscopy (Bellamy et al. 1997) or hydrogen gas clearance (Machens et al. 1995) . The non-traumatic instrumentation and in particular non-traumatic access to the gastric mucosa allows the determination of mucosal oxygenation in the absence of surgical stress. This is particularly desirable with respect to the marked alterations surgical stress exerts on splanchnic circulation (Gelman 1976) . In this situation reflectance spectrophotometry reliably detects even clinically asymptomatic reductions in mucosal oxygenation (Fournell et al. 2003) and highly correlates with the morphologic severity and extent of gastric mucosal tissue injury (Sato et al. 1986 ).
Systemic hemodynamics and oxygenation
The aorta was catheterized via the left carotid artery for continuous measurement of mean arterial pressure (MAP, Gould-Statham pressure transducers P23ID, Elk Grove, IL, USA) and intermittent withdrawal of blood samples for measurement of blood gas tensions including carboxyhemoglobin (CO-Hb) and acid-base related variables (Rapidlab 860, Bayer AG, Germany). Arterial oxygen content (CaO 2 ) and systemic oxygen delivery (DO 2 = CaO 2 × cardiac output) were calculated. Cardiac output was determined via transpulmonary thermodilution (PiCCO 4.2 non US, PULSION Medical Systems, Munich, Germany) at the end of each intervention, at least every 30 minutes, as described elsewhere (von Spiegel 1996) .
Heart rate (HR) was continuously measured by electrocardiography (Powerlab, ADInstruments, Castle Hill, Australia). All hemodynamic and respiratory variables were recorded on a personal computer after analoge to digital conversion (Powerlab, ADInstruments, Castle Hill, Australia) for later analysis.
Carbon monoxide
Carbon monoxide was either inhaled or infused intravenously. For inhaled application, CO (Kohlenmonoxid 4.7, Linde AG Gas und Engineering, Leuna, Germany) was mixed with oxygen-enriched air (F i O 2 = 0.25) and sevoflurane to achieve an inspiratory concentration of 100 ppm which was continuously measured (Draeger Pac 5000, Draegerwerk AG & Co. KGaA, Luebeck, Germany). To infuse CO normal saline (0.9% NaCl) was bubbled with 100% CO (Linde AG) for 20 minutes at room temperature and atmospheric pressure resulting in a concentration of about 0.93 × 10 -4 M (CO = 28.01 molecular weight and 0.0026 g/100 ml solubility in water at 20°C) (Hangai-Hoger 2007) . Blood volume (BV) was estimated at 80 ml/kg body weight. The animals received 10 %BV of saline or CO-saline as a single infusion over 10 min.
Hypovolemia
Hypovolemia was induced by hemorrhage (withdrawal of 16 ml kg -1 of whole blood over five minutes that is 20% of the estimated total blood volume, via a large bore intravenous catheter in a femoral vein and the arterial catheter). Heparinized shed blood was stored and later retransfused using an infusion set with a 200 µm filter.
Experimental program
Following the instrumentation, 30 min were allowed to establish steady state conditions and baseline values were recorded before the animals were randomized to the respective protocol (Fig. 1) .
Inhaled CO
After baseline recordings, the animals were ventilated either with 100 ppm CO (inhal 100ppm/hem ) or without (inhal 0ppm/ hem ) until the end of the observation period. After 30 minutes hemorrhage was induced as described above and shed blood was retransfused after 60 min, all variables were recorded for another 60 min.
Infused CO
In a second series, the animals received either a CO-saturated saline solution (intrav CO/hem ) or saline (intrav saline/hem ) over 10 min, followed by hemorrhage and retransfusion of the shed blood, as detailed above.
In a control series, animals received either CO-saline (intrav CO ) or saline (intrav saline ) without any further intervention to exclude time related effects.
At the end of each intervention, blood samples were obtained for blood gas analysis.
Statistical analysis
Data for analysis were obtained during the last five minutes of each intervention under steady state conditions. Normal Figure 1 . Experimental protocol. Interventions of all groups over time course from 0:00 to 03:00 hours. After baseline recordings for 30 minutes, the animals were continuously ventilated either with 100 ppm CO (group inhal 100ppm/hem ) or without (group inhal 0ppm/hem ), followed by hemorrhage after 1 hour and retransfusion of the shed blood after 2 hours. In the following groups, after baseline recordings the animals received either a CO-saturated saline solution 'CO-saline' (group intrav CO/hem ) or saline (group intrav saline/hem ) over 10 min, followed by hemorrhage and retransfusion, as detailed above. In a control series, animals received either CO-saline (group intrav CO ) or saline (group intrav saline ) without any further intervention. data distribution was confirmed by the Kolmogorov-Smirnov test (StatView V4.1, SAS-Institute Inc., Cary, NC, USA). All data are presented as absolute values of mean ± standard deviation (mean ± SD) for n = 6 animals per group in the first series and n = 5 in the second series, because one animal died before completion of all experiments. Differences within the groups were tested using an analysis of variance for repeated measurements (ANOVA) and a Fisher's PLSD test as post hoc test (StatView V4.1, SASInstituteInc, Cary, NC, USA). p < 0.05 was considered significant.
Results
Both inhalative and intravenous application of CO increased carboxyhemoglobin. This, however, did not alter microvascular hemoglobin oxygenation of the mucosa neither under physiological conditions nor after hemorrhage.
Inhalative protocol
Inhalation of air containing 100 ppm CO increased CO-Hb from 5.4 ± 0.6 to 6.3 ± 1.0% after 30 min and finally to 9.6 ± 1.0% at the end of the observation period, whereas COconcentration remained unchanged during time control experiments without carbon monoxide (inhal 0ppm/hem ). This, however, had no effect on µHbO 2 which remained unchanged and almost identical in both groups (Fig. 2) . During hemorrhage, µHbO 2 decreased in both groups without significant differences between the groups, consistent with a decrease of oxygen delinery (DO 2 ) and was restored after retransfusion of the shed blood. Further variables are shown in Table 1 and 2.
Intravenous protocol
Infusion of a CO-saturated solution increased CO-concentration from 5.6 ± 0.6 to 6.4 ± 0.7% (intrav CO ) and from 4.8 ± 0.1 to 5.9 ± 0.1% (intrav CO/hem ) without any further changes over time. At the end of the observation period maximum CO-Hb levels were lower after intravenous than inhalative application. During control experiments (intrav saline /intrav saline/hem ) CO-Hb remained unchanged. Again, this did not have an effect on µHbO 2 in any group. µHbO 2 decreased during hypovolemia, increased after retransfusion to baseline values and did not change in both groups without hemorrhage ( Fig. 3 and 4) . The decrease during hemorrhagic shock is related to the decrease of DO 2 , which is due to a decreased cardiac output. The increase of CO-Hb did not show any influence on µHbO 2 . Further variables are shown in Table 1 78 ± 3 79 ± 3 59 ± 9* 58 ± 8* 75 ± 5 78 ± 7 inhal 100ppm/hem 76 ± 6 74 ± 5 53 ± 4* 59 ± 4* 72 ± 5 77 ± 3 inhal 0ppm/hem 79 ± 2 78 ± 3 55 ± 9* 54 ± 7* 69 ± 5 79 ± 4 DO 2 (ml/kg/min) intrav CO 11 ± 2 11 ± 2 11 ± 2 11 ± 2 10 ± 2 10 ± 2* intrav saline 12 ± 2 12 ± 2 12 ± 2 12 ± 2 12 ± 2 12 ± 2 intrav CO/hem 11 ± 1 11 ± 1 7 ± 1* 8 ± 1* 11 ± 1 11 ± 1 intrav saline/hem 12 ± 1 12 ± 1 9 ± 1* 9 ± 1* 12 ± 1 12 ± 1 inhal 100ppm/hem 12 ± 1 12 ± 1 8 ± 1* 8 ± 1* 12 ± 1 12 ± 1 inhal 0ppm/hem 12 ± 1 12 ± 1 7 ± 1* 9 ± 1* 12 ± 1 12 ± 1* Cardiac output (ml/kg/min) intrav CO 75 ± 9 81 ± 10* 78 ± 10 80 ± 9* 77 ± 9 75 ± 8 intrav saline 75 ± 9 79 ± 9 77 ± 8 77 ± 7 77 ± 6 75 ± 7 intrav CO/hem 74 ± 5 79 ± 6 53 ± 4* 58 ± 4* 79 ± 5 79 ± 6 intrav saline/hem 77 ± 7 84 ± 7 58 ± 6* 61 ± 4* 84 ± 6 82 ± 5 inhal 100ppm/hem 87 ± 8 87 ± 7 55 ± 6* 59 ± 5* 86 ± 6 86 ± 6 inhal 0ppm/hem 83 ± 7 82 ± 6 52 ± 3* 60 ± 4* 85 ± 5 86 ± 6 SVR (mmHg·min/l) intrav CO 32 ± 5 28 ± 4* 30 ± 4* 30 ± 4* 31 ± 4 31 ± 4 intrav saline 31 ± 3 28 ± 2* 30 ± 2 31 ± 2 30 ± 2 31 ± 2 intrav CO/hem 30 ± 2 27 ± 2* 34 ± 2* 34 ± 2* 31 ± 1 29 ± 1 intrav saline/hem 29 ± 2 26 ± 2 33 ± 2* 33 ± 1* 31 ± 1 29 ± 1 inhal 100ppm/hem 27 ± 2 27 ± 2 33 ± 2* 36 ± 2* 31 ± 1* 29 ± 1 inhal 0ppm/hem 27 ± 2 27 ± 1 34 ± 2* 35 ± 2* 32 ± 1* 28 ± 1
MAP (mmHg)
intrav CO 62 ± 3 59 ± 3* 61 ± 3 62 ± 3 62 ± 3 61 ± 3 intrav saline 62 ± 3 61 ± 3* 62 ± 3 64 ± 3* 64 ± 3* 64 ± 3* intrav CO/hem 61 ± 2 59 ± 2 49 ± 2* 54 ± 3* 68 ± 3* 64 ± 3 intrav saline/hem 61 ± 1 60 ± 1 51 ± 2* 56 ± 2* 71 ± 4 66 ± 3 inhal 100ppm/hem 62 ± 1 63 ± 1 49 ± 3* 57 ± 3 72 ± 3* 66 ± 2* inhal 0ppm/hem 60 ± 1 61 ± 1 49 ± 2* 56 ± 3 75 ± 2* 66 ± 1* HR (1/min) intrav CO 108 ± 8 104 ± 6 103 ± 7* 102 ± 6* 101 ± 6* 98 ± 6* intrav saline 108 ± 8 105 ± 7 104 ± 7* 103 ± 7* 102 ± 7* 100 ± 6* intrav CO/hem 106 ± 4 103 ± 4 99 ± 4* 103 ± 5 98 ± 4* 95 ± 4* intrav saline/hem 107 ± 5 105 ± 4 104 ± 4 106 ± 4 100 ± 4 97 ± 5* inhal 100ppm/hem 110 ± 6 109 ± 5 104 ± 4 109 ± 5 104 ± 5* 101 ± 6* inhal 0ppm/hem 111 ± 6 110 ± 6 111 ± 4 114 ± 5 107 ± 5 103 ± 6* Effects of inhaled or infused carbon monoxide under hemorrhage (for 30 min "Hemorrhage 1" and 60 minutes "Hemorrhage 2") and retransfusion (after 30 min "Retransfusion 1" and 60 min "Retranfusion 2") on gastric microvascular mucosal oxygen saturation (µHbO 2 ), oxygen delivery (DO 2 ), cardiac output, systemic vascular resistance (SVR), mean arterial pressure (MAP) and heart rate (HR). Data presented as absolute values, n = 6 per group for inhaled CO and n = 5 per group for infused CO, mean ± SD; * p < 0.05 versus baseline. intrav CO 5.6 ± 0.6 6.4 ± 0.7* 6.6 ± 0.7* 6.4 ± 0.8* 6.5 ± 0.6* 6.6 ± 0.8* intrav saline 4.5 ± 0.1 4.7 ± 0.1 4.8 ± 0.2* 4.7 ± 0.1 5.0 ± 0.1* 5.0 ± 0.1* intrav CO/hem 4.8 ± 0.1 5.9 ± 0.1* 5.4 ± 0.1* 5.3 ± 0.1* 5.8 ± 0.1* 5.8 ± 0.1* intrav saline/hem 4.9 ± 0.2 4.9 ± 0.1 4.8 ± 0.1 4.9 ± 0.1 5.2 ± 0.2* 5.1 ± 0.2 inhal 100ppm/hem 5.4 ± 0.6 6.3 ± 1.0 6.6 ± 1.0 7.5 ± 1.0* 8.8 ± 1.0* 9.6 ± 1.0* inhal 0ppm/hem 6.7 ± 0.8 7.2 ± 1.0 6.8 ± 0.9 6.4 ± 0.8 6.3 ± 0.7 6.3 ± 0.7 pO 2 (mmHg)
intrav CO 107 ± 9 111 ± 10 112 ± 11 113 ± 11 109 ± 9 109 ± 9 intrav saline 110 ± 10 113 ± 9 109 ± 7 115 ± 8 113 ± 10 116 ± 10 intrav CO/hem 107 ± 9 116 ± 9 112 ± 11 108 ± 11 118 ± 10* 116 ± 10 intrav saline/hem 100 ± 8 107 ± 7* 99 ± 6* 105 ± 9 111 ± 7* 111 ± 8* inhal 100ppm/hem 97 ± 10 100 ± 10 99 ± 9 99 ± 9 107 ± 10* 105 ± 10* inhal 0ppm/hem 101 ± 8 102 ± 6 93 ± 4 106 ± 9 106 ± 7 106 ± 6 pCO 2 (mmHg) intrav CO 37 ± 1 38 ± 1 37 ± 1 38 ± 1 39 ± 2 38 ± 2 intrav saline 38 ± 2 37 ± 1 37 ± 1 38 ± 1 38 ± 1 38 ± 2 intrav CO/hem 38 ± 1 38 ± 1 42 ± 1* 40 ± 2* 41 ± 1* 41 ± 2* intrav saline/hem 37 ± 1 36 ± 1 40 ± 1* 39 ± 1* 38 ± 1 39 ± 1* inhal 100ppm/hem 36 ± 1 37 ± 1* 39 ± 1* 39 ± 1* 37 ± 1 37 ± 1 inhal 0ppm/hem 36 ± 1 36 ± 1 38 ± 1 38 ± 1 37 ± 1 37 ± 1* pH ctHb (g/dl)
intrav CO 11.4 ± 1.0 11.0 ± 0.9 11.0 ± 1.0 10.6 ± 1.1* 10.7 ± 1.2 10.6 ± 1.2* intrav saline 12.9 ± 0.8 12.2 ± 0.9 12.3 ± 1.0 12.3 ± 0.9 12.3 ± 1.1 12.3 ± 1.0 intrav CO/hem 11.8 ± 0.7 11.1 ± 0.7* 11.3 ± 0.6* 11.1 ± 0.6* 11.1 ± 0.7* 11.1 ± 0.7* intrav saline/hem 12.4 ± 0.8 11.6 ± 0.7* 11.5 ± 0.8* 11.6 ± 0.7* 11.6 ± 0.7* 11.7 ± 0.7* inhal 100ppm/hem 11.6 ± 0.7 11.7 ± 0.4 11.7 ± 0.3 11.6 ± 0.2 11.5 ± 0.3 11.6 ± 0.3 inhal 0ppm/hem 11.9 ± 1.0 11.9 ± 0.7 12.0 ± 0.9 11.9 ± 0.8 11.9 ± 0.7 11.9 ± 0.8
Effects of inhaled or infused carbon monoxide under hemorrhage (for 30 minutes "Hemorrhage 1" and 60 minutes "Hemorrhage 2") and retransfusion (after 30 minutes "Retransfusion 1" and 60 minutes "Retranfusion 2") on carboxyhemoglobin (CO-Hb), arterial oxygen tension (pO 2 ), arterial carbon dioxide tension (pCO 2 ), pH and total hemoglobin (ctHb); data presented as absolute values, n = 6 per group for inhaled CO and n = 5 per group for infused CO, mean ± SD; * p < 0.05 versus baseline.
Discussion
Critique of methods
Repetitive experiments were performed on six healthy, chronically instrumented dogs in randomized order. As each dog underwent each of the protocols it served as its own control minimizing interindividual differences. Between two experiments with the same animal an interval of at least two weeks was guaranteed to ensure complete recovery of the animals and to prevent carryover effects.
Carbon monoxide
Carbon monoxide induces acute and chronic toxicity in high doses with increased CO-Hb but is also produced endogenously with a physiological role as a signalling molecule (Boehning and Snyder 2003) , exerting protective and vasoactive effects (Bauer and Pannen 2009) . Those protective effects can be triggered by low doses of exogenous CO that do not increase CO-Hb to toxic levels and are known to be dose-dependent (Hangai-Hoger 2007) . Therefore, we tested the concentration of infused CO on gastric circulation known to have the greatest impact on circulation in other tissues (Hangai-Hoger 2007) with little effect on CO-Hb. Recent studies have shown that low doses of CO affect microcirculation even without increasing CO-Hb (Guo et al. 2004; Hangai-Hoger 2007) . The low dose of inhaled CO used in this study has been shown to have cytoprotective and anti-inflammatory effects in previous studies (Bathoorn et al. 2007 ) whereby the mechanisms are largely unknown but will be discussed below. The aim was to analyze whether those cytoprotective concentrations of CO induce macro-or microcirculatory disturbances regarding systemic or local oxygenation in the gastric mucosa.
Thus, the low dose of CO was sufficient to increase COHb only to a small amount similar to intravenous application without inducing toxic effect and was therefore adequate to analyze effects on microcirculatory circulation and oxygenation.
Though, long-term effects of CO as a modulator of heme biosynthesis and as an oxygen sensor (Dubin 2007) on the gastric oxygenation cannot be analyzed in this short observation period. Additionally, CO can induce suspended animation, a phenomenon similar to hibernation, and could improve survival during hypoxia and sepsis (Kajimura et al. 2010 ). This phenomenon cannot be observed in this short period. Yet, our hemorrhagic shock model is adequate to observe short-term vasoactive effects of CO, especially under hemorrhagic conditions and during therapeutic blood transfusion. Nevertheless, we analyzed one dose and cannot rule out the possible usefulness of CO at other doses.
Interpretation of the results
In contrast to human beings the animals started off at quite high CO-Hb values, however, these values are common in dogs and similar CO-Hb values in dogs have been reported elsewhere previously (Wack 2005) .
CO under physiological conditions
Both inhaled and infused CO increased CO-Hb only to a small amount without effect on local or systemic oxygenation. Therefore, presumed cytoprotective effects of low dose CO can be further investigated and applied without compromising microvascular oxygenation. The only small increase of CO-Hb might be due to self-inhibition. CO is known to autoinhibit HO and thus its own synthesizing enzyme. While endogenous CO does not inhibit HO reaction (Marks et al. 2002) , larger amounts of exogenous CO attenuated this reaction (Yoshida et al. 1980) . Nevertheless, the reported vasodilatory effects of other studies (Hartsfield et al. 2004; Nishikawa et al. 2004; Kanu et al. 2006; Hosgood et al. 2008) could not be observed in this experiment. One reason might be that some of these studies analyzed isolated organs (Hosgood et al. 2008 ) and the shown effects might not become evident in a whole organism. Other in vivo animal studies did not use application of exogenous CO but instead indirect endogenous generation via HO-1 stimulation (Hartsfield et al. 2004; Nishikawa et al. 2004; Kanu et al. 2006 ). These reported HO-mediated vasodilatory effects might not be CO-related or demonstrate a difference between endogenous and exogenous effects of CO on the µHbO 2 . Another difference to invasive measurements (Nishikawa et al. 2004; Hangai-Hoger 2007 ) is our non-traumatic approach which enables measurement under physiological conditions. This is important because surgical manipulation alters blood flow (Gelman 1976 ). Though we used equal concentrations to previous studies showing vasodilatory effects, we still do not know the local tissue concentration of CO in gastric vasculature. CO has to cross the membranes by diffusion, although the existence of transport is discussed. Thus, the diffusion and hence intracellular concentration depends on the above mentioned conditions of the local environment which might be different in gastric mucosa compared to the hamster window chamber model and other studies. Especially for gastric gland cells it has been shown that their permeability for gaseous molecules is extremely reduced (Waisbren et al. 1994 ). However, this has not been shown for CO and gastric gland cells are not comparable to gastric vasculature. Differences in local tissue concentrations of CO might be an explanation for our diverging results, especially since vasodilatory effects have been shown to be concentration-dependent (Hangai-Hoger 2007) . Still, at the moment there is no sufficient method to estimate intracellular CO-concentration, e. g. in the gastric mucosa, in vivo.
Furthermore CO might regulate vascular tone mainly by modulation of the generation of NO, and its actions seem to depend in part on colocalization of the NO-synthase and HO with sCG (Kajimura et al. 2010) . Colocalization might be different in the hamster window chamber model and explain different effects of CO on different tissues.
Another likely reason for our divergent results is the different approach in our study, which is the first to analyze microvascular oxygenation rather than perfusion.
The reported CO related improvement of survival after gut ischemia (Nakao et al. 2003) and in septic animals (Chung et al. 2008 ) is -according to our results -not related to an improved oxygenation and maintained gut barrier but rather to long-term, immunomodulatory effects of CO (Bauer and Pannen 2009 ) as well as enhanced colonic cell restitution. These anti-inflammatory effects are reduction in myeloperoxidase activity, reduced production of keratinocyte chemoattractant and tumor necrosis factor-α along with inhibited nuclear translocation of NF-κB (Takagi et al. 2010) . Enhanced colonic epithelial cell restitution after CO treatment to myofibroblasts is related to increased fibroblast growth factor 15 expression via inhibition of microRNA miR-710 (Uchiyama et al. 2009 ).
CO under hemorrhagic conditions
Especially during hypovolemia CO might play a crucial role, as it is known to reduce organ damage under hemorrhage (Sakai et al. 2009 ). Furthermore, under stress conditions enhanced production of CO due to induction of HO could be observed (Maines 1997) . Under hemorrhage this might be important in the neurotransmission of the enteric nervous system (Boehning and Snyder 2003) and especially in gastrointestinal vessels (Zakhary et al. 1996) .
Nevertheless, even during hemorrhagic shock CO did not alter microvascular oxygenation in our study. The expected effects might be important in the long term, i.e. by enzyme induction, but could not affect oxygenation under hemorrhage in this short observation period. Still, our results suggest that cytoprotective and immunomodulatory effects can be used in hemorrhagic shock without compromising local oxygenation. This oxygenation is important for the maintenance of the gut barrier function (Trzeciak et al. 2007 (Trzeciak et al. , 2008 , which is most probably not affected by CO.
Conclusions
In summary, despite the previously reported increase of perfusion in different tissues triggered by CO, the same dose does not affect gastric microcirculation at the same time.
